Resins and Gums in Historical Iatrosophia Texts from Cyprus - A Botanical and Medico-pharmacological Approach. by Lardos, A et al.
Original research article
published: 01 July 2011
doi: 10.3389/fphar.2011.00032
Ethiopia, or Somalia (Serpico, 2000, p. 438; Langenheim, 2003, 
pp. 257–267). In the following centuries the incense road leading 
from the south-coast of the Arabian Peninsula northwards to the 
Mediterranean coast was established and by 500 BCE a substantial 
trade existed with the ancient Greek world (Langenheim, 2003, 
pp. 283–287). Resins were not only brought to the Mediterranean 
but the region itself is notable for a number of resin producing 
trees, shrubs, or herbs (Howes, 1950). Pedanius Dioscorides (first 
century CE), in his περὶ ὕλης ἰατρικῆς (peri yle¯ s iatrike¯ s), bet-
ter known by its Latin title De Materia Medica, mentioned that 
styrax, mastic, scammony, various coniferous resins, as well as 
ladanum and resin of the terebinth could be obtained from places 
in the Eastern Mediterranean. For the latter two he particularly 
noted Cyprus as provenance (Berendes, 1902; Chrysanthis, 1942). 
Archeological excavations at Pyrgos–Mavrorachi, a metallurgic 
Bronze age site near the south-coast of the island dated to the 
nineteenth century BCE brought several relicts of plant exudates 
to light, some of them were identified as pine or terebinth resins 
(Lentini, 2004, cited in Hadjikyriakou, 2007, pp. 50, 154–55). A 
Mycenaean tablet of the same era mentioned a substance called 
ki-ta-no, now interpreted as terebinth resin which appears to 
have been imported to Crete from Cyprus or Syria (Karageorghis, 
1996, p. 66).
IntroductIon
The present study is part of a larger project which explores the 
herbal materia medica and its use in historical iatrosophia texts from 
Cyprus as well as modern herbal knowledge in the island’s mon-
asteries where some of these texts were written. The term iatroso-
phia (ιατροσóϕια), meaning medical wisdom, can be applied 
to both orally transmitted medicinal recipes and corresponding 
medical texts in Greek. This study focuses on the textual sources 
which constitute themselves a special genre of medical literature 
of Byzantine origin.
Among the many drugs described in these texts, resins, 
and gums are endowed with a special relevance. Humans have 
employed resins for very diverse purposes including esthetic, 
ceremonial, or therapeutic uses but also in arts and industry. 
As they often belonged to the most sought after materials, they 
have been traded between the different cultures around the world 
from the earliest times. Around the middle of the second mil-
lennia before the Common Era (CE) trade routes were estab-
lished which brought resins to the Mediterranean region. Amber 
from the Baltic region was traded to the Mycenaeans and the 
Phoenicians brought the material by ship from northern Europe. 
Frankincense or myrrh was supplied to Egypt from of a place 
called Punt, which is believed to have lied in the region of Sudan, 
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We previously investigated the species contained in a iatroso-
phia text from Cyprus (Lardos, 2006). The fact that quite a num-
ber of plant exudates were mentioned in this text together with 
the absence of published studies which discuss this specific class 
of natural products in the context of historical medical texts has 
prompted us to undertake the present study. Here we apply a special 
procedure for unlocking information on species and their uses in 
up to now non-translated and largely unedited iatrosophia texts. 
Based on the classification of medicinal uses into greater categories 
we highlight similarities and differences between the iatrosophia 
and (i) Dioscorides’ De Materia Medica, (ii) historic pharmaceu-
tical books from the era when plant drugs were still included in 
mainstream medicine, and (iii) authoritative texts of modern phy-
totherapy which serve as scientific standards of herbal medicinal 
products in Europe. By implementing specific points of the protocol 
for analyzing historical texts by Buenz et al. (2004) we attempt to 
examine the validity of the medicinal uses mentioned in the texts 
by comparing them with reported bioactivity data and at the same 
time identify previously unexplored cases.
IatrosophIa texts
Many earlier historians showed little enthusiasm for the iatrosophia, 
considering them as “diluted and clouded extraction of ancient 
knowledge with all sorts of superstitious ingredients and invoca-
tions” (e.g., Bloch, 1902, p. 512). As commonly understood today, 
these texts developed in the context of Byzantine hospitals where 
they served as handbooks for the daily medical practice containing 
recipes and therapeutic advice (Varella, 1999, p. 579; Touwaide, 
2007, pp. 160–161). They can best be described as therapeutic 
compendia, which contain extracts from classical or Byzantine 
sources and which often were reproduced on previous compila-
tions (Touwaide, 2007, p. 149). Earliest examples might reach back 
to the tenth century CE but they certainly became abundant from 
the fifteenth century onwards (Touwaide, 2007, p. 149; Zisper, 2009, 
p. 9). After the end of the Byzantine Empire (1453) hospitals of the 
Byzantine tradition were restricted to Greek orthodox monasteries 
spread over many parts of the previous empire or to monastic foun-
dations in great cities now part of Greece or Turkey. The tradition 
of the iatrosophia continued in these monasteries but also in the 
secular environment among the Greek-speaking population of the 
Ottoman Empire. The examples produced in this era had a marked 
influence on the medicine of this group of population (Varella, 
1999, pp. 579–583). As illustrated by the text of a traditional healer 
from Crete or the one from a monastery in Cyprus this tradition was 
continued until the first decades of the twentieth century (Clark, 
2002, p. 339; Lardos, 2006).
The existing literary sources available for the compilation of the 
first iatrosophia texts included the healing lore of Greek and Roman 
antiquity and the earlier Byzantine time. Such a list would prob-
ably include the Hippocratic texts, Dioscorides, and Galen. Perhaps 
of greater importance were the Byzantine authors like Oribasius, 
Aetios of Amida, Alexander of Tralles and Paulus Aegineta. They 
wrote between the fourth and seventh century CE (Scarborough, 
1984, pp. 213, 221–229). By consulting the works of contemporary 
scholars the writers of the iatrosophia might also have included 
elements of Arabic/Islamic medicine. Islamic medicine, which had 
hitherto borrowed from Byzantium exerted a marked influence on 
Byzantine therapeutic practice from the tenth century CE onwards 
and especially between the thirteenth and fourteenth century CE 
(Varella, 1995; Bennett, 2000; Touwaide, 2007, pp. 163–164). The 
writers of the hospital and medical craft texts (virtually the iatroso-
phia) distilled what they found useful from the available sources 
and supplemented it with new information. Brevity as well as easy 
access to reliable recipes and recorded practical experience from 
the bedside was what counted most for them (Bennett, 2000, pp. 
280–281; Touwaide, 2007, pp. 150–154, 160–161). As Clark (2002, p. 
358) could demonstrate by investigating a iatrosophion from Crete 
– written in 1930 – a commitment to preserve the past combined 
with the capacity to adapt to changed conditions and incorporate 
new learning are inherent qualities of this tradition.
Today, several iatrosophia texts have survived in monasteries 
or private collections in Greece or Cyprus (Varella, 1999, p. 580; 
Lardos, unpublished results). Individual manuscripts are also 
stored in public libraries for example in London, Oxford, Paris, 
and Vienna (Touwaide, 2007, p. 156; Zisper, 2009, pp. 14–27). In a 
survey including roughly 700 Greek medical manuscripts produced 
during the Ottoman era it was found that 45% of them belong to 
this category (Varella, 1999, p. 578). The lack of existing inventories 
and difficulties in identifying corresponding texts in the bulk of 
medical manuscripts are major points which hampered the study of 
the iatrosophia in the past. To counteract this drawback Touwaide 
(1992, p. 75) has launched a research program to establish a com-
puterized inventory of all Greek medical manuscripts currently 
known in library collections (Touwaide, 2007, pp. 156–157).
HIstorIcal texts from tHe medIterranean as an 
etHnopHarmacologIcal researcH tool
With the ongoing socio-structural changes in the societies of the 
Mediterranean region local, mainly orally transmitted knowledge 
about the uses of plants as medicine and food appears to be declin-
ing. It has been demonstrated that in this area information on the 
local use of plants is increasingly restricted to people of middle age 
or beyond (Nebel et al., 2006; Gonzalez-Tejero et al., 2008). The 
consequence of the generational shift with the associated loss of 
knowledge has forced researchers to emphasize the importance to 
gather endangered knowledge but also to define creative ways how 
to reintroduce this knowledge to younger generations of the local 
societies (Nebel et al., 2006; Hadjichambis et al., 2008). While the 
loss of pre-existing knowledge seems to be unavoidable to some 
extent, other perspectives to access information on plant use have 
opened up. Historical texts from the various medical traditions 
in and around the Mediterranean basin have become established 
as a rewarding tool for ethnobotanical or ethnopharmacological 
research. A number of studies have been published recently which 
analyzed and contextualized the content of written sources from this 
area (Lardos, 2006; López-Muñoz et al., 2006; Pardo-de-Santayana 
et al., 2006; Touwaide, 2007, pp. 168–173; Lev and Amar, 2008; 
Pollio et al., 2008; Leonti et al., 2009; De-Vos, 2010; Leonti et al., 
2010). Historical texts can also provide a unique gateway to discover 
new medicinal agents. One prominent example to illustrate the role 
such texts could play in this respect is Gerard’s “Herball” (see, e.g., 
Buenz et al., 2004; Cordell and Colvard, 2005). Since its publication 
in Britain at the end of the sixteenth century, eighteen different 
pharmaceuticals were developed from plants that are described in 
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known as a source for the material have now been classified into 
the CITES Appendix II (Ito and Honda, 2005). As illustrated by 
Langenheim (2003, p. 466) at the example of resin use in tropi-
cal ecosystems, the challenge, here too, is to develop “a balance of 
economic success and sustainable management.”
materIals and metHods
searcH for IatrosophIa texts
This study involves six iatrosophia texts (Table 1) to which we have 
gained access through a hand-search in various libraries in Cyprus 
and the United Kingdom as well as in the 21 monasteries taking part 
in the ethnobotanical field study in Cyprus as part of the overall 
project. Most of the texts seem to have been in circulation on the 
island during the Ottoman (1571–1878) and British era (1878–
1960) (Kargotis, 1951; Chrysanthis, 1966). They were written by 
monks (IM, GP – see Table 1 for the full names of the texts) and 
traditional healers (KYP) or stood in connection to some priests 
(IPM, IPP). While two of the six (IM, KYP) were demonstrably 
produced in Cyprus, the status of further three (IPM, IPP, KI) is 
ambiguous in this respect. The Geoponikon (GP) from Agapios 
Landos originates from Crete but printed copies of the manuscript 
were produced in Venice as early as 1643 (Kostoula, 1991) and dis-
tributed in Cyprus in the following centuries (Spanopoulos, 1935, 
p. 53; Georgiadis, 1995, p. 134). In all but one case (KYP) the texts 
could be accessed using print editions of the original manuscript.
this source and 16 of those became approved drugs (Cox, 1998). 
It has been argued that a careful and systematic re-examination of 
medicinal plants mentioned historical texts provides an invaluable 
source for the development of new drugs (Holland, 1994; Riddle, 
1996, 2002; Buenz et al., 2004; Fiore et al., 2005). Recent studies 
were able to corroborate many of the plant uses in historical texts 
with reported biological activities or identify promising candidates 
for the development of new drugs (Buenz et al., 2005; Adams et al., 
2009, 2011). The previously unexplored atun tree (Atuna racemosa 
Raf., Chrysobalanaceae) from Samoa which had been identified as 
candidate in the text analysis of Rumphius’s Ambonese Herbal in 
fact exhibited a pharmacological activity that corresponded to the 
historical use (Buenz et al., 2006).
classIfIcatIon and propertIes of resIns and gums
To define resins and to group them various concepts representing 
different scientific approaches and disciplines have been suggested. 
Based on the fact that resins usually are intermixed with other exu-
dates three groups are commonly recognized: resins, balsams, and 
gum resins (Wolff-Berlin, 1928, p. 50). Resins dissolved in volatile 
oils are generally called balsams. However, for some researchers 
balsams are a type of oleo resins restricted to phenolic resins mainly 
composed of benzoic or cinnamic acids and their esters. Resins 
mixed with polysaccharides are called gum resins or oleo gum resins 
if they additionally contain volatile oils (Howes, 1950; Berger, 1964, 
pp. 1–3; Bruneton, 1995, p. 224). All these resinous exudates can 
also be classed by the main chemical components of the fraction 
that is soluble in organic solvents. In doing so, two main groups 
can be distinguished, terpenoid and phenolic resins. Terpenoid 
resins predominantly contain mono- or sesquiterpenes in their 
volatile and di- and triterpenes in their non-volatile fraction while 
in phenolic resin phenylpropanoids or lipophilic flavonoids are the 
major groups of compounds. Additionally several mixed resins are 
known or such which do not fit in these categories (Langenheim, 
2003, pp 23–44, 306, 341, 412).
As a consequence of this phytochemical diversity, gums, and 
resins have often been confused and both terms are used rather 
loosely (Hepper, 1987; Langenheim, 2003, pp. 23–24, 45). Exudate 
gums are amorphous solids which basically consist of mixtures 
of polysaccharides (Boer and Ella, 2000, p. 15). They are readily 
distinguished from resins and products of a rubbery nature by 
the fact that they are miscible with water but insoluble in organic 
solvents (Howes, 1949, p. 5). Depending on their solubility proper-
ties in water true gums can be divided in soluble, insoluble and half 
soluble or semi-insoluble gums (Howes, 1949, p. 5; Mantell, 1949).
Most resins are obtained by tapping or applying incisions to 
the bark of trees or shrubs. The exudate is collected either when 
still fluid or in a solid state after the more volatile compounds have 
evaporated. Such harvesting methods are dramatic interventions 
for the plant organism and can lead to its debilitation. Moreover, the 
industrial exploitation of wild populations of resin or gum produc-
ing species raises concerns in terms of biodiversity. For example, 
Pistacia atlantica trees from which fruits are collected to extract 
terebinth oil should not be tapped since this would have a negative 
impact on the fruit production (Panaretos, 1979). Because of the 
recent overexploitation of agar wood several Aquilaria species are 
threatened with extinction, as a consequence all Thymelaeaceae 
Table 1 | The six investigated iatrosophia texts.
Text- Original manuscript Working copya Rec.b 
code Title Text type 
 Author (year), Editor (year), 
 Place of origin Place
GP Geoponikon Print edition 143
 Agapios Landos (1585–1656) D. D. Kostoula (1991), +64*
 Crete GR, edit. Venice, 1643 Volos GR
IM Iatrosophikon Antidotarion Print edition 493
 Mitrophanous (1790–1867) Filaretos (1924),
 Mon. of Makhairas CY, 1849 Makhairas CY
IPM Iatrosophi tou Papa Michaïli Print edition 39
 ? Michaïlis G. Petridis (2000),
 ? Vasa (Koilani) CY, undated Limassol CY
IPP Iatrosophikon Papa tis Petras Print edition 13
 Anonymous G. I. Spanopoulos (1935),
 ? Petra CY, ca. eighteenth century Nicosia CY
KI Ena Kypriako Iatrosophi Print edition 67
 Anonymous K. Chrysanthis (1951),
 ? CY, undated Nicosia CY
KYP Kyprianarion Manuscript (copy) 24
 Velephantou (1913), Anonymous (1978),
 Lefkosia (Nicosia) CY Athens GR
Total number of recipes containing plants as ingredients 779
aSee reference list for full citations.
bCounted number of recipes which contain plants as ingredients and which are 
destined for use in humans.
*In addition to the 143 recipes, 64 chapters dealing with plants and their virtues 
were counted.
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Extraction and translation (steps 1 and 2)
The information was extracted by reading through the entire text. All the 
texts were written in the vernacular Greek of the respective time, some 
of them with a Cypriot-Greek coloring. The language is relatively well 
comprehensible to a reader with knowledge of Modern Greek. When 
required, specific dictionaries, etymological lexica (Hadjiioannou, 
2000; Papangellou, 2001), or glossaries (Myrianthopoulos, 1925; 
Kostoula, 1991) were consulted. The disorders or symptoms that were 
mentioned in a recipe were first translated using popular medicinal 
and medicinal literature or glossaries dealing with the topic of the 
local nomenclature of diseases (Myrianthopoulos, 1925; Kyriazis, 1926; 
Chrysanthis, 1944, 1988; Kyprianou, 1987). Ancient names of condi-
tions were cross-checked with their correspondents in the “Deutsches 
 Krankheitsnamen-Buch” (Höfler, 1899). Complementary information 
protocol for tHe analysIs of IatrosophIa texts
For analyzing the texts a multi-step protocol was developed 
(Figure 1). In steps 1 and 2 information about the use of plants 
was extracted and itemized according to recipe or chapter, substance 
name, part used, mode of preparation, way of application, and use. 
Every mentioning of a substance in one of the texts was entered 
in the database as a separate record (the term “substance” is used 
as a substitution for both plant and plant part or product in the 
consecutive text). The resulting inventory provided the base for the 
second part of the protocol (steps 3–6) which involved the selec-
tion of a specific substance class, the identification of the species 
and the categorization of the uses. The third part of the protocol 
involved the investigation from a medicinal and pharmacological 
point of view (steps 7–10).
FiguRE 1 | Flowchart of the 10 steps in the analysis of the iatrosophia texts. Steps 3 and 6 were also applied on other texts (i.e., Dioscorides’ De Materia 
Medica, historic pharmaceutical books and standard texts of modern phytotherapy) and served to establish a separate inventory of resins and gums of their owns.
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After the identity had been established the substance was assigned 
to the appropriate botanical source based on the information in 
up-to-date or if necessary also earlier pharmacognostic reference 
books (Richter, 1827; Tschirch and Stock, 1935/1936; Howes, 1949; 
Berger, 1964; List et al., 1972; Langenheim, 2003; Blaschek et al., 
2007; Nussinovitch, 2010) and other scientific literature. In cases 
where the respective species can be found in Cyprus this was done 
using the “Flora of Cyprus” (Meikle, 1977/1985) or other botani-
cal literature on the local flora (Della, 1999; Tsintides et al., 2002; 
Hadjikyriakou, 2007). All references were cross-checked. Scientific 
plant names were checked with the Tropicos, Missouri Botanical 
Garden2, or International Plant Name Index3.
Quantification and categorization of the use reports into use groups 
(steps 5 and 6)
Following the approach of Kufer et al. (2005) every use of a substance 
mentioned in one of the texts was counted as one use report (UR). 
Records referring to identical uses of a substance within the same 
text were considered duplicates and removed from the list. Finally, 
every medicinal use was categorized into 1 of the 12 pre-established 
medicinal use groups (UGs) largely based on body systems: CA – 
Cardiovascular and blood, EE – Ears and eyes, DE – Dermatological, 
FV – Fevers (including malaria), GI – Gastrointesinal and hepatic, 
GY – Gynecological, HA – Headache and migraine, MS – Musculo-
sceletal, OC – Oral cavity, RE – Respiratory tract, UG – Urogenital, 
VA – Various conditions.
Comparison to uses mentioned in other texts (step 7)
To reveal similarities of the use pattern of a substance, a comparison 
was conducted between the UGs treated by the uses mentioned in 
iatrosophia and those mentioned in: (i) Berendes’ (1902) German 
translation of De Materia Medica of Dioscorides; (ii) Western phar-
maceutical books from the era before plant drugs were largely aban-
doned from mainstream medicine including British Pharmaceutical 
Codex, 2nd Edition (Council of the Pharmaceutical Society of Great 
Britain, 1911) and United States Dispensatory (Remington and Woods, 
1918). They both were accessed via the online catalog of Henriette’s 
Herbal Homepage; (iii) Authoritative standard texts of phytotherapy 
in Europe including German Commission E Monographs (BGA, 
1978–1994), British Herbal Compendium, Volume 1 (Bradley, 1992), 
Potter’s Herbal Cyclopedia (Williamson, 2003), Hagers Enzyklopädie 
der Arzneistoffe und Drogen (Blaschek et al., 2007) and ESCOP mono-
graphs (ESCOP, 2009). For this purpose, every medicinal use of a sub-
stance mentioned in these references was categorized into one of the 
12 UGs [see Quantification and Categorization of the use Reports into 
Use Groups (Steps 5 and 6)]. For each substance the established UGs 
were then juxtaposed to those in iatrosophia and evaluated based on the 
number of UGs of the substances the compared texts had in common.
Comparison to reported bioactivity data (step 8 and 9)
To enable a one-to-one association between the substance and the 
mentioned use the detailed comparison to reported bioactivity data 
was conducted involving only simple remedies. These are remedies 
that include only one active substance, as opposed to compound 
including the general medical situation and the diseases prevalent on 
the island at that time was drawn from books on the local history of 
medicine (Koureas, 2006; Marangou and Georgiadis, 2006; Stavridis, 
2006). Particular care was taken to retain the original wording of a use 
mentioned in a text. The translated use was then cross-checked with a 
German edition of “Harrison’s principles of internal medicine” (Dietel 
et al., 2003) or “Health Topics” of the Medline Plus database1 and if 
required transcribed into the appropriate clinical term. To accomplish 
this, a clear understanding of the mentioned condition was essential. 
However, many of the medicinal uses were ambiguous and sometimes 
difficult to link to a particular clinical term. For example, the condition 
“wound on the leg that opens again and again out of its own” can be 
interpreted as a chronic wound perhaps associated with infection and 
inflammation or more specifically a venous ulcer.
selection of records and identification of the substances (steps 3 and 4)
From the established basic inventory records referring to resin and 
gum exudates were selected. These also included related products 
such as volatile oil separated through distillation of the resin or 
wood tar which usually was obtained through a dry distillation by 
burning resinous wood in an oven (Blaschek et al., 2007).
By applying linguistic and pharmacognostic criteria a substance 
was first identified on the basis of the substance name and then 
assigned to the appropriate botanical source. To establish the iden-
tity of a substance the iatrosophia name was cross-referenced with 
plant or substance names listed in:
(i) Historical texts including De Materia Medica of Dioscorides 
(Berendes, 1902; Wellmann, 1906/1907/1914) and the 
“Medical Compendium in Seven Books” of Paulus Aegineta 
(Adams, 1844/1846/1847; Heiberg, 1921/1924). They were 
available in Ancient Greek as digitized texts from TLG® 
(Thesaurus Linguae Graecae), University of California, Irvine 
and in English or German translations as scanned books inclu-
ding also commentaries about the identity of drugs and their 
sources. Berendes’ (1902) German translation of Dioscorides 
was accessed via the online catalog of Heilpflanzen-Welt 
(multi MED vision GbR) and Adams’ (1844/1846/1847) 
English translation of Paulus Aegineta downloaded as PDF 
file from Bibliothèque Interuniversitaire de Medicine et d’O-
dontologie, Paris. In addition appropriate publications on the 
materia medica of historical texts of ancient Greek, Byzantine, 
medieval Arabic/Islamic, and Ottoman origin which listed 
original names were consulted (Langkavel, 1866; Tschirch and 
Lippmann, 1933; Riddle, 1987; Varella, 1995; Aliotta et al., 
2003; Lev and Amar, 2008; Ölker and Direkçi, 2009).
(ii) Lexica, glossaries, etymological keys, and botanical litera-
ture containing beside Greek also Cypriot-Greek or Turkish 
names (Gennadios, 1914; Myrianthopoulos, 1925; Panaretos, 
1967; Kostoula, 1991; Viney, 1994; Hadjiioannou, 2000; 
Papangellou, 2001; Hadjikyriakou, 2007).
(iii) Miscellaneous references including popular medicinal, 
 pharmaco-historical, and ethnobotanical literature as well as 
dictionaries of the Greek or Turkish language (for all referen-
ces see Table 2).
1http://www.nlm.nih.gov/medlineplus/
2http://www.tropicos.org/
3www.ipni.org
Lardos et al. Historical iatrosophia texts from Cyprus
www.frontiersin.org July 2011 | Volume 2 | Article 32 | 5
Table 2 | identification of the substance names mentioned in the iatrosophia.
Name in iatrosophiaa Correspondent nameb Cent.c Referenced Substancee
bouchoúr yiági buhur yagˇı 16 Ölker and Direkçi (2009) Storax, liquid (exotic grade)
bouchoúri yag 19 Hanbury (1857)
bukhur yaghy 19 Hanbury (1857)
bohur 20 Viney (1994, p. 250)
katráni, katrán qatrân 10 Tschirch and Lippmann (1933, p. 1361) (1) Cedar tar
qitrân 11–13 Lev and Amar (2008, p. 497)
katran ≤19 Lev (2002)
katran 21 Lev and Amar (2002)
qitrân 11–13 Lev and Amar (2008, p. 497) (2) Pine tar
kara katran 21 Sezik et al. (2001)
katrámi, katrás ≤20 Gennadios (1914, p.782) (3) Wood tar (of conifers)
katránin, katrás ≤21 Papangellou (2001)
kechripárin, chechripárin kechrimpári ≤20 Gennadios (1914, p. 411) Amber (fossilized resin)
kechripárin ≤20 Myrianthopoulos (1925)
kechrimpári 21 Webster’s Online Dictionaryd
kechriparóladon kechrimpári // ládi, -ládo 21 Webster’s Online Dictionaryd Amber oil
kómmi arapikón, kómmi 
aravikón
komide¯ arapiko¯n 03–13 Langkavel (1866, p. 1.2) Gum arabic 
kómmi aravikón ≤20 Gennadios (1914, p. 28)
aravikó kómmi 21 Webster’s Online Dictionaryd
kommídi kommi […] amygdale¯s, 
-keraso¯n, -tes kokkomyleas
01 Berendes (1902, 1.157, 174, 176), Wellmann 
(1906/1907/1914, 1.113, 121, 123)
Gum of various Prunus species 
such as almond, cherry, plum
kerasia […] kommi, 
kokkyme¯leas […] kommi
07 Adams (1844/1846/1847, 7.3, 167, 180), 
Heiberg (1921/1924, 7.3.21)
kommídi ≤20 Gennadios (1914, p. 534)
komídin ≤20 Myrianthopoulos (1925)
kómmi 20 Panaretos (1979)
kommídi tis kerasiás, komídi 
(=píssa) tis kkerashiás
kommi to¯n keraso¯n 01 Berendes (1902, 1.157), Wellmann 
(1906/1907/1914, 1.113)
Cherry gum
kerasia […] kommi 07 Adams (1844/1846/1847, 7.3, 167), Heiberg 
(1921/1924, 7.3.10)
kérasos […] kommi ≤20 Gennadios (1914, p. 492)
komídin […] tis keraséas, 
píssa tis keraséas
≤20 Myrianthopoulos (1925)
komídi (kolitsána) tou 
moúsklou kai tou damaskínou
kommi te¯s kokkomyleas 01 Berendes (1902, 1.157, 174, 176), Wellmann 
(1906/1907/1914, 1.113, 121, 123)
Plum gum
kokkyme¯leas […] kommi 07 Adams (1844/1846/1847, 7.3, 180), Heiberg 
(1921/1924, 7.3.21)
moúskla (kokomílo) ≤20 Kostoula (1991)
damáskino 21 Webster’s Online Dictionaryd
ládanon le¯danon, ladanon ≤02 
BCE
Arnold-Apostolides (1985, p. 396); Riddle 
(1987, p. 59)
Ladanum
ladanon 01 Berendes (1902, 1.128), Wellmann 
(1906/1907/1914, 1.97)
ladanon 07 Aliotta et al., (2003, p. 7.3, 208), Heiberg 
(1921/1924, 7.3.11)
ládanon ≤20 Gennadios (1914, p. 512)
(Continued)
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ládin tou kapnismátou kápnisma ≤20 Gennadios (1914, p. 972) Storax, liquid (local grade)
kápnisma 20 Panaretos (1979)
kápnisma (tou Ayíou 
Neophútou)
21 Hadjikyriakou, (2007, p. 102)
lívanos (arsenikós), lívanos 
áspros
libanos, libano¯tos (arse¯n) ≤02 
BCE
Aliotta et al.,(2003, p. 395), Riddle (1987,  
p. 59)
Frankincense (olibanum)
libanos 01 Berendes (1902, 1.81), Wellmann 
(1906/1907/1914, 1.68)
libano¯tos 07 Adams (1844/1846/1847, 7.3, 217), Heiberg 
(1921/1924, 7.3.11)
lívanos ≤20 Gennadios (1914, p. 202)
machmoudiá machmoutá 03–13 Langkavel (1866, p. 146.1) Scammony
mahmûda 11–13 Lev and Amar (2008, p. 280)
mahmûde, mahmudiye otu 16 Ölker and Direkçi (2009)
mamoutiá ≤20 Gennadios (1914, p. 764)
machmoudiá ≤20 Myrianthopoulos (1925)
mastíchin mastiche¯ 01 Berendes (1902, 1.90), Wellmann 
(1906/1907/1914, 1.70)
Mastic
mastiche¯ 07 Adams (1844/1846/1847, 7.3, 243), Heiberg 
(1921/1924, 7.3.12)
mastiche¯ ≤20 Gennadios (1914, p. 640)
mastíchin ≤20 Papangellou (2001)
mávron kápnisman (=chalváni ) chalbane¯ ≤02 
BCE
Aliotta et al., (2003, p. 400) Galbanum
chalbane¯ 01 Berendes (1902, 3.87(97)), Wellmann 
(1906/1907/1914, 3.83)
chalbane¯ 07 Adams (1844/1846/1847, 7.3, 398), Heiberg 
(1921/1924, 7.3.22)
galvánon, chalváni ≤20 Gennadios (1914, p. 218)
chalváni ≤20 Myrianthopoulos (1925)
mýrra, mýrra dialektí mýrra, smýrna ≤20 Gennadios (1914, p. 170) Myrrh
mýrra ≤20 Myrianthopoulos (1925)
mýrra 21 Webster’s Online Dictionaryd
mýrra xylalá xylaloe¯ 11 Tschirch and Lippmann (1933, p. 1348), 
Varella (1995)
(1) Agar wood, gaharu wood, 
aloe wood (lignum aloes)
xylalás ≤20 Gennadios (1914, pp. 2–3)
xylalás ≤20 Hadjiioannou (2000)
xylalás ≤20 Papangellou (2001)
mýrra ≤20 Gennadios (1914, p. 170) (2) Myrrh
mýrra ≤20 Myrianthopoulos (1925)
neft yiági néfti ≤20 Gennadios (1914, p. 825) Pine turpentine oil
neft yiagí ≤20 Myrianthopoulos (1925)
neft yagˇı 21 Webster’s Online Dictionaryd
píssa áspri tou péfkou, píssa 
péfkou áspri (=retsína), píssa, 
píssa tou péfkou, retsína, 
retsíni tou péfkou
re¯tine¯ […] peukine¯ 01 Berendes (1902, 1.92), Wellmann 
(1906/1907/1914, 1.71)
Pine resin (resina alba 
communis), crude turpentine 
(terebinthina), rosin 
(colophonium)
Table 2 | Continued
Name in iatrosophiaa Correspondent nameb Cent.c Referenced Substancee
(Continued)
Lardos et al. Historical iatrosophia texts from Cyprus
www.frontiersin.org July 2011 | Volume 2 | Article 32 | 7
re¯tinai […] peukine¯ 07 Adams (1844/1846/1847, 7.3, 317), Heiberg 
(1921/1924, 7.3.17)
retsína […] ton péfkon ≤20 Gennadios (1914, p. 824–825)
píssa […] tis péfkis ≤20 Myrianthopoulos (1925)
píssa, retsínan apó ta péfka 20 Panaretos (1979)
píssa mávri píssa […] mávri ≤20 Myrianthopoulos (1925) Pine resin, cooked (resina 
nigra) 
píssa 20 Panaretos (1979)
mávri píssa ≤20 Papangellou (2001)
píssa pikrís amygdaliás, píssa 
tis athashiás tis pikrís 
amygdale¯s […] kommi 01 Berendes (1902, 1.176), Wellmann 
(1906/1907/1914, 1.123)
Bitter almond gum 
athashiá […] píssa ≤20 Myrianthopoulos (1925)
athashiá […] píssa ≤20 Papangellou (2001)
píssa […] amygdaliés 20 Panaretos (1979)
píssa tis elaías dakryon […] elaia 01 Berendes (1902, 1.141), Wellmann 
(1906/1907/1914, 1.105)
Olive resin
dakryon […] agrian elaian 07 Adams (1844/1846/1847, 7.3, 100), Heiberg 
(1921/1924, 7.3.5)
elaiodákryon ≤20 Gennadios (1914, p. 265)
píssa tou xylalá xylaloe¯ 11 Tschirch and Lippmann (1933, p. 1348), 
Varella (1995)
(1) Agar wood, gaharu wood, 
aloe wood (lignum aloes)
xylalás ≤20 Gennadios (1914, p. 2–3)
xylalás ≤20 Hadjiioannou (2000)
xylalás ≤20 Papangellou (2001)
píssa tou xylalá ≤20 Gennadios (1914, p. 783, 923) (2) Benzoin
píssa tou xylalá ≤20 Myrianthopoulos (1925)
píssa tou xylalá 20 Arnold-Apostolides (1985) (3) Storax, solid (styrax)
píssa tou xylalá 20 Panaretos (1967)
sarí katrán qitrân 11–13 Lev and Amar (2008, p. 497) Cypress tar
sarí katrán 20 Chrysanthis (1940)
servi 20 Viney (1994, p. 4)
servi 21 Hadjikyriakou, (2007, p. 55)
smýrna smyrna ≤02 
BCE
Riddle (1987, p. 59) Myrrh
smyrne¯ 01 Chrysanthis( 1940, p. 1.77), Wellmann 
(1906/1907/1914, 1.64)
smyrne¯ 07 Adams (1844/1846/1847, 7.3, 348), Heiberg 
(1921/1924, 7.3.18)
mýrra, smýrna ≤20 Gennadios (1914, p. 170)
trimintína, trementína re¯tine¯ terebinthine¯ 01 Wellmann (1906/1907/1914, 1.66), Berendes 
(1902, 1.91)
(1) Terebinth resin
re¯tine¯ terebinthine¯, 
terebinthine¯
07 Adams (1844/1846/1847, 1.45, 58, 3.22., 414), 
Heiberg (1921/1924, 1.45.1, 3.22.13)
tremantine¯ 03–13 Langkavel (1866, p. 11.4)
trimintína 18–19 Hadjikyriakou (2007, p. 153)
trimintína 20 Chrysanthis (1942)
trementína 20 Panaretos (1979)
Table 2 | Continued
Name in iatrosophiaa Correspondent nameb Cent.c Referenced Substancee
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trementína ≤20 Gennadios (1914, p. 825) (2) Crude turpentine of the pine 
(terebinthina)
trimintína píssa ≤20 Myrianthopoulos (1925)
tzam sákkizi tzam […] sakiz ≤20 Gennadios (1914, p. 768, 824–25) Pine resin
çam sakızı 20 Honda et al. (1996)
çam sakızı 21 Webster’s Online Dictionaryd
trimintína venétini trementína // Venetía 21 Webster’s Online Dictionaryd Venice turpentine
válsamon tis Mékkas válsamon tis Mékkas ≤20 Gennadios (1914, p. 170) Balsam of Mecca
válsamon tis Mékkas ≤20 Myrianthopoulos (1925)
aNames are listed as mentioned in the texts. The transliteration of the substance names in Latin letters basically follows the ISO code 843 1997 TR for Modern Greek 
with a few adjustments to improve the approximation of the code to the correct phonetic reproduction (e.g., Greek γι- as yi- at the beginning of a word; Cypriot-Greek 
-σια as -sha).
bNames mentioned in the cited reference, which were considered a match with the corresponding iatrosophia name. For the conversion of Ancient or Medieval 
Greek names (references until 1453 CE) the transliteration scheme of the American Library Association ALA-LC 1997 for Greek of The Library of Congress was used 
[http://www.loc.gov/catdir/cpso/roman.html (accessed December 03, 2010)].
cCentury, -ies (CE) from which the correspondent name is documented based on the cited references. Cases referring to BCE are specified.
dhttp://websters-online-dictionary.org/
eIdentity of the iatrosophia name based on the information contained in the cited references. In cases where the name can refer to more than one substance, all 
possible interpretations are separately listed and indicated with individual numbers (e.g., 1, 2, 3).
Table 2 | Continued
Name in iatrosophiaa Correspondent nameb Cent.c Referenced Substancee
remedies which contain two or more of them. The method was 
adopted from the protocol for analyzing historical texts intro-
duced by Buenz et al. (2004, 2005) and included two basic steps, the 
extrapolation of the pharmacological functions of a substance and 
the cross-referencing to reported bioactivity data. In a first step the 
pharmacological therapy required for the treatment of the respective 
condition was looked up in “Goodman and Gilman’s pharmacologi-
cal basis of therapeutics” (Brunton et al., 2006) or “Health Topics” of 
the Medline Plus database4. The pharmacological properties of the 
suggested therapy were deduced or, if specified, directly adopted and 
assigned to the respective substance as presumable pharmacological 
functions. In doing so, we relatively strictly adhered to the informa-
tion stated in these references and at the same time disregarded less 
common causes of a respective disease. The procedure is illustrated by 
the following example: According to recipe GP PMH 05 crude gum 
Arabic should be eaten to stop the “flux of the belly,” which according 
to Höfler (1899, p. 29, “Bauchfluss”) is diarrhea. Most cases of diar-
rhea are caused by a disturbed intestinal water and electrolyte balance 
or altered intestinal motility, a medical intervention would include 
liquid- and electrolyte replacement, bulk-forming agents, motility, 
or secretory inhibitors. Diarrhea can also be associated with inflam-
matory bowel disease or microbial infection (Brunton et al., 2006). 
Assuming that gum Arabic would in fact be able to influence diar-
rhea bulk-forming, antimotility, antisecretory, anti-inflammatory, 
or antibiotic effects are likely to be involved in its action. Next, the 
Web of Knowledge (ISI Web of Knowledge Service for UK Education, 
Thomson Reuters) and EMBASE (Elsevier Science Publishers) were 
surveyed for bioactivity data of the respective substance using flex-
ible combinations of substance or species name together with the 
deduced pharmacological functions as search words. The reported 
activities were then compared with the associated pharmacological 
functions and cross-referenced.
Comparison to ethnomedical information (step 10)
The simple remedies in iatrosophia were compared to De Materia 
Medica of Dioscorides (Berendes, 1902) and “Medical Compendium 
in Seven Books” of Paulus Aegineta (Adams, 1844/1846/1847). 
Dioscorides had a distinct influence on the development of the 
medicinal knowledge in areas from northern Europe to the Indian 
Ocean (Riddle, 1985, p. xvii). Paulus Aegineta’s early Byzantine 
work is a “distillation of classical drug theory which captured the 
essence” (Scarborough, 1984, p. 229). As he wrote before the emer-
gence of Arabic/Islamic medicine an influence on his work from 
this side could be excluded.
results and dIscussIon
IdentIty of tHe substances and tHeIr botanIcal sources
The identification of plant exudates mentioned in historical texts is 
notoriously difficult. Before determining the botanical source the 
substance itself has to be identified by referencing to names cited in 
the literature. For this purpose we also consulted annotated historical 
texts. However, several problems remain in terms of the identifica-
tion of plants mentioned in ancient texts (Piomelli and Pollio, 1994). 
As highlighted by Riddle (1985, p. xxv), the various authorities who 
sought to identify the plants mentioned in Dioscorides’ De Materia 
Medica do not always agree and there are real possibilities for error. 
Dawkins (1936) was of the opinion that ancient plant names can 
only be interpreted with certain vagueness and Raven et al. (2000) 
additionally highlighted the unreliability of some identifications in 
authoritative dictionaries of ancient Greek plant names.
We were in the comfortable situation that the majority of the 
over 40 substance names of resins, gums, and related products 
encountered in the iatrosophia (Table 2) were common names 
which are still known today. In only two cases either no entirely 
matching (mýrra xylalá – myrrh or agar wood) or only one cor-
respondent name (sarí katrán – cypress tar) could be found in 
the literature and this leaves the established identity particularly 4http://www.nlm.nih.gov/medlineplus/
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Inventory of resIns and gums
The 27 substances were used as ingredients in 118 recipes which 
corresponded to 224 URs (9.4% of the total URs in our database; 
Table 3). Since a recipe may contain more than one plant ingredient 
and can be indicated for manifold uses the number of URs exceeds 
the number of recipes. The great majority of the URs concerned 
medicinal uses, only nine were non-medicinal ones such as the use 
as paint for church icons or incense. The by far most important 
use was for dermatological conditions accounting for 35.8% of all 
medicinal URs followed by gastrointestinal and hepatic conditions 
(18.6%) and respiratory tract diseases (12.1%; Figure 2). Of the 
26 substances used medicinally 14 were applied both orally and 
topically, some of them even in a scent remedy, and others either 
only orally (seven) or topically (five). Altogether nine of them were 
listed in more than five medicinal recipes.
Of those, mastic is the substance most frequently mentioned, the 
resin was used as an ingredient in 42 recipes. Conditions distributed 
over 10 of the 12 UG were identified, in particular dermatological (17 
URs), respiratory (16 URs), gastrointestinal and hepatic (14 URs), 
and ears and eyes (10 URs). Although Pistacia lentiscus is a wide-
spread shrub in the Mediterranean, the main source of supply for 
commercial mastic has apparently always been the Eastern Aegean 
island of Chios. Here, the resin is harvested by making incisions to the 
bark of the small trees of P. lentiscus var. chia (Desf.) Poir. (Flückiger 
and Hanbury, 1874, pp.142–145; Howes, 1950; Serpico, 2000, p. 434).
Products of pines such as resins, turpentine oil, and wood tar 
were mentioned in overall 30 recipes. Recipes, which included 
crude or cooked pine resins were distributed over 7 UGs, above 
all dermatological complaints (17 URs). Until the early twentieth 
century the collection of pine resin and the production of tar in 
particular from Pinus brutia or P. nigra subsp. pallasiana was of 
some commercial importance in Cyprus (Zeilinger, 1997, p. 140; 
Tsintides et al., 2002, pp. 77–79; Hadjikyriakou, 2007, pp. 47–49).
Frankincense also called olibanum was mentioned in 28 recipes. 
The conditions they treated were distributed over 8 UGs and mainly 
concerned dermatological (20 URs) but also gastrointestinal and 
hepatic or urogenital uses (each with 6 URs). Southern Arabia and 
African regions south of Egypt were the main provenances of the 
oleo gum resin (Serpico, 2000, p. 439). Several Boswellia species 
of this area produce frankincense, of certain importance are B. 
sacra from southern Oman and Yemen, B. carteri, B. frereana, B. 
bhau-dajiana from Somalia and B. papyrifera from Sudan, Ethiopia, 
and other places in East Africa (Howes, 1950; Serpico, 2000, pp. 
438–439; Langenheim, 2003, p. 363; Blaschek et al., 2007).
Terebinth resin was mentioned in 20 recipes distributed over four 
medicinal UGs. The majority of the uses concerned dermatological 
(16 URs) followed by gastrointestinal and hepatic (4 URs) conditions. 
Blaschek et al. (2007) as earlier Tschirch and Stock (1935/1936, 2.2.1, 
p. 383) indicate Pistacia terebinthus as the source. In contrary, botani-
cal references on resin producing terebinths from Cyprus mention 
P. atlantica and not to P. terebinthus (Chrysanthis, 1942; Panaretos, 
1967; Tsintides et al., 2002, p. 258; Hadjikyriakou, 2007, pp. 152–155). 
This inconsistency was highlighted by Meikle (1977/1985, p. 368) 
and it has been suggested that the confusion owed to variations in 
past botanical nomenclature considering P. atlantica as a variety of 
P.  terebinthus (Mills and White, 1989). In the past, Cyprian turpen-
tine or Cyprus balsam, in fact, had some importance as an item of 
uncertain. However, in the majority of the other cases at least 
three correspondents in Greek, Turkish, and sometimes Arabic 
were found enabling a straightforward attribution to a defined 
substance. They included Cypriot-Greek vernacular names (e.g., 
píssa tis athashiás tis pikrís – bitter almond gum) and trade names 
(e.g., válsamon tis Mékkas – balsam of Mecca) or such that can be 
traced far back in history, sometimes for two millennia or more 
(e.g., lívanos – frankincense, ládanon – ladanum, mastíchin – 
mastic). Assuming that over the centuries the name has not been 
applied to different herbal drugs, this demonstrates a remarkable 
continuity of the popular plant nomenclature of the respective 
cases. Sibthorp was surprised when locals he met on his botanical 
excursions to Greece in 1787 used the nomenclature of Dioscorides 
and Theophrastus to name the plants (Bruce, 1970). Although 
Fraas (1845, p. ix), who contributed to the exploration of the local 
flora in the nineteenth century CE, was clearly more skeptical 
and argued that many plant names of the Greek antiquity had 
recently been reintroduced into the Greek language to purport a 
cultural continuity, he admitted that particularly among the names 
of cultivated plants such with true ancient roots could be found. 
Hanlidou et al. (2004) showed that a great number of the herbs 
sold on the market of Thessaloniki today have names which are 
related to those in Dioscorides.
More difficulties posed those substance names with several pos-
sible interpretations. They could be attributed to different material 
obtained from sometimes taxonomically unrelated species (e.g., tri-
mintína – terebinth resin or crude pine resin, píssa tou xylalá – agar 
wood, benzoin, or solid storax). Perhaps typical for plant exudates, 
in many cases the botanical source is not restricted to one single 
species because the material simply can be collected from several 
more or less closely related taxa. This appears to be connected with 
traditional concepts of species demarcations which do not neces-
sarily overlap with those of the Linnean binomial nomenclature. 
Cases like these can best be comprehended by considering them as 
plant complexes as suggested by Linares and Bye (1987). A group 
of different species consisting of one “label” plant and several sub-
stitutes share the same name and have common qualities and uses.
Finally, the identification procedure yielded a list of at least 
27 different substances (Table 3). With the help of standard texts 
and additional appropriate references they could be attributed to 
their respective botanical source. However, in the case of cedar 
tar and cypress tar the attribution is ambiguous because of the 
lack of corresponding information in the available references. The 
27 substances were obtained from over 43 taxa out of 13 families 
and included various kinds of resins, gums, tars, and volatile oils. 
Seven of the resins could be categorized as terpenoid resins obtained 
from species which are members of the Anacardiaceae, Burseraceae, 
and Pinaceae. Phenolic resins were only found in the Styracaceae. 
Various of them were of miscellaneous nature containing substan-
tial portions of both terpenoid and phenolic compounds, belong-
ing to the Altingiaceae, Apicaceae, Cistaceae, and Convolvulaceae. 
Five of the substances were pure gums belonging to the Rosaceae 
and Fabaceae. Twelve of the substances were obtained from exotic 
species originating from Southeast Asia, Middle East, Europe and 
the neighboring region. The botanical sources of the remaining 15 
substances were trees and shrubs which can be found in the Cypriot 
flora either spontaneously growing or cultivated.
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FiguRE 2 | Distribution of the use reports (uRs) of records referring to 
resins and gums over the 12 medicinal use groups [key to the 
abbreviations see Quantification and Categorization of the use Reports 
into use groups (Steps 5 and 6)].
commerce for the island (Thiselton-Dyer, 1885; Tschrich and Stock, 
1935/1936, p. 2.2.1, 384). Today,  specifically in the Pafos area, the resin 
is still collected to produce a traditional chewing gum called pafitikí 
píssa (Mills and White, 1989; Hadjikyriakou, 2007, p. 153).
Overall 10 recipes can be associated with agar wood, they treated 
conditions distributed over 6 UGs. Agar wood is the fragrant resin-
ous wood of trunk and roots from several tropical Thymelaeaceae in 
particular Aquilaria species of Southeast Asia (Langenheim, 2003, 
p. 448). As suggested by an account from the fourteenth century, 
“aloe wood” was actually available in medieval Cyprus (Heyd, 1879, 
p. 9, 559). Interestingly, agar wood or aloe wood was not referred 
to by Dioscorides’ name agallocho¯n (Berendes, 1902, 1.21) but 
by (píssa tou) xylalá, the Cypriot-Greek reproduction of xylaloe¯ 
(Gennadios, 1914, pp. 2–3) and provides a clue about the origin 
of this knowledge. Simeon Seth, a Jewish Byzantine doctor of the 
eleventh century, who played an important role in the transmission 
of Eastern, in particular Islamic medicine, to the Byzantine Empire, 
seems to be the first of the Greek writing authors who described 
the drug in detail by using the name xylaloe¯ (Langkavel, 1866, p. xi 
17t; Tschrich and Lippmann, 1933, p. 1348; Varella, 1995).
Nine of the above recipes can also be associated with benzoin or 
solid storax both obtained from members of the Styracaceae. Two 
different kinds of benzoin are recognized; Sumatra benzoin from 
Styrax benzoin and S. paralleloneurum, both found in Indonesia 
and Malaysia, and Siam benzoin from S. tonkinensis found in 
Laos, Thailand, Vietnam, and Malaysia or other related species 
(Blaschek et al., 2007). The first report which unequivocally refers 
to this resin comes from the fourteenth century Arab traveler 
Ibn Batuta. It was suggested that the Arabic name luban djawi 
(frankincense of Java) was later changed to banjawi to finally 
give benjoin or benzoin (Flückiger and Hanbury, 1874, p. 362; 
Tschirch and Lippmann, 1933, p. 1383). The only representative 
Lardos et al. Historical iatrosophia texts from Cyprus
www.frontiersin.org July 2011 | Volume 2 | Article 32 | 13
Sardinia, Sicily, and Campania (Italy; Leonti et al., 2009, 2010). 
The iatrosophia too show remarkable parallels with Dioscorides’ 
text. Roughly two-thirds (18 of 26) of the plant exudates used 
medicinally here were already listed in this ancient treatise, 16 
of them showed some degree of consistency in the UGs and 8 
out of these were used to treat conditions of exactly the same 
UGs. Of all 74 UGs included in the iatrosophia and associated 
with these 18 substances, 46 UGs (62.2%) are also found in De 
Materia Medica (Table 4). On the other hand changes in terms of 
numbers and kinds of UGs of substances common to both sys-
tems were observed. In particular the only moderate consistency 
in the UGs of substances which were well known to Dioscorides, 
some of them originating from the Eastern Mediterranean, such 
as frankincense, mastic, pine resins, and agar wood or solid storax 
is notable. While in iatrosophia agar wood, amber, frankincense, 
and mastic were used in a more diverse way, for almond gum, 
galbanum, ladanum, and olive resin this was the case in De Materia 
Medica. In fact, the mean number of UGs treated per substances 
was even higher in the latter (4.6) than the former (3.6) indicat-
ing that in general a substance was used in more diverse ways in 
De Materia Medica. Analogous results were reported by Leonti 
(2011) based on a comparison between recent field-based studies 
from Campania with Matthioli’s edition of Dioscorides (Leonti 
et al. 2010). Those substances not mentioned in Berendes’ (1902) 
translation of Dioscorides concerned tars and volatile oils or res-
ins of local and exotic species (benzoin, balsam of Mecca, liquid 
storax). They appear to have been introduced in later centuries, 
some of them perhaps via Islamic medicine as illustrated by the 
case of benzoin (see Inventory of Resins and Gums). The differ-
ences to Dioscorides altogether may be linked to changes in the 
prevalence of diseases or the influence of other sources.
The comparison to historic pharmaceutical books and modern 
standard texts of phytotherapy reflects the gradual decline of the 
use of plant exudates in Western medicine and simultaneously 
demonstrates the presence of substances in the iatrosophia which 
have never become established here. While 16 of the 26 substances 
were mentioned in historic pharmaceutical books only 11 of them 
remained in the modern standard texts of phytotherapy. Similarly, 
14 cases showed some degree of consistency in the UGs between 
iatrosophia and historic pharmaceutical books, only nine cases 
did so between iatrosophia and the phytotherapy texts. Of all 
65 UGs included in the iatrosophia and associated with the 16 
substances used in the historic pharmaceutical books, 41.5% 
(27 UGs) are also found in the latter. The analogous percentage 
of the phytotherapy texts is 34.8% (16 UGs; based on 46 UGs 
included in the iatrosophia and associated with 11 substances; 
Table 4). The mean number of UGs treated per substance was 
slightly lower than in iatrosophia (3.6), namely 3.0 in the historic 
pharmaceutical books and 2.5 in the phytotherapy texts. While the 
highest number of same UGs was found with the uses of myrrh 
mentioned in the historic pharmaceutical books (five of six UGs), 
substances with a wide range of indication in iatrosophia such as 
mastic or frankincense had an overall low degree of consistency 
(10–30%). The general reduction in the use of plant exudates is 
partly due to the fact that for several reasons in modern phyto-
therapy old uses were abandoned. A substance may have become 
obsolete, at least for certain indications or applications, because 
of the Styracaceae in the Mediterranean and native to Cyprus is 
Styrax officinalis (Meikle, 1977/1985), the source of solid storax. 
It should be noted that the substance commonly known by the 
name storax or styrax today is the exudate from Liquidambar 
species (see, e.g., Hovaneissian et al., 2006). However, according 
to Hanbury (1857) the original and classical storax was the “solid 
storax” produced by S. officinalis which in modern times disap-
peared from commerce and was replaced by the “liquid storax” 
obtained from Liquidambar orientalis. This view is adhered to in 
up-to-date standard texts (see, e.g., Blaschek et al., 2007). There is 
a still ongoing dispute whether S. officinalis does produce a resin at 
all. In morphological studies of stem samples from trees growing 
near Izmir (western Turkey) no resin production was observed 
and, therefore, Zeybek (1971) concluded that plants from this part 
of Anatolia do not produce it. However, based on reports of resin 
producing trees in southeastern Turkey, the author underscored 
the potential importance of geographical varieties. Interestingly, 
both Dioscorides (Berendes, 1902, 1.79) and Pliny (Bostock and 
Riley, 1855, p. 12.55) in writing about styrax, mentioned that the 
product comes from places now in southeastern Turkey, west-
ern Syria, or Lebanon but also from Cyprus and Crete. In fact, 
Hadjikyriakou (2007, p. 229) provided photographic evidence 
of fresh running resin on a previously injured stem of a living S. 
officinalis tree from a place at the entrance of the Karpas peninsula 
in northeastern Cyprus.
Myrrh was mentioned in nine recipes including uses distributed 
over 8 UGs. The majority of them concerned respiratory (6 URs) 
and gastrointestinal and hepatic conditions (5 URs). The gum resin 
is collected from several species of the large genus Commiphora, a 
commonly accepted source is C. molmol (C. myrrha var. molmol; 
Serpico, 2000, pp. 439–442; Blaschek et al., 2007).
Ladanum was mentioned in seven recipes the uses of which 
concerned 3 UGs. Both Dioscorides (Berendes, 1902, 1.128) and 
Pliny (Bostock and Riley, 1855, p. 12.37) stressed that the pre-
ferred quality of ladanum comes from Cyprus while the other 
main provenance was Arabia including the district bordering Syria. 
Ladanum had been collected and even exported from the island 
at least until the end of the nineteenth century (Thiselton-Dyer, 
1885; Gennadios, 1914; Warren, 2002). Of the four indigenous 
Cistus species only Cistus incanus subsp. creticus (syn. Cistus creticus 
and Cistus villosus var. creticus) plays a role as a source of ladanum 
here, as well as on Crete (Warren, 2002). Hadjikyriakou (2007, pp. 
172–174) mentions Cistus creticus L. subsp. creticus as the source 
of ladanum which in contrary to subsp. eriocephalus (Viv.) Greuter 
et Burdet, the other local infraspecific taxon, is glandular, strongly 
resinous and aromatic. In Meikle (1977/1985) the names Cistus 
creticus L. var. creticus and var. tauricus (Presl) Dunal, respectively, 
are used.
relatIonsHIp to dIoscorIdes and Western standard texts
Conceptually, this comparative analysis joins similar approaches 
based on retrospective explorations of diachronic data as illus-
trated by Heinrich et al. (2006). Of specific relevance for the present 
case are findings suggesting a substantial influence of Dioscorides’ 
De Materia Medica on the development of both the materia medica 
in European historical texts (De-Vos, 2010) and the orally trans-
mitted popular medicine in regions of the Mediterranean such as 
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Table 4 | Comparison of the substances and ugs included in the iatrosophia to those of other texts.
 
Iatros.
 Dioscorides’ De Materia Medica Historic pharmaceutical books Modern phytotherapy texts
Substancesa #ugsb incl.c #ugsb #Same 
ugsd
%Same 
ugse
incl.c #ugsb #Same 
ugsd
%Same 
ugse
incl.c #ugsb #Same 
ugsd
%Same 
ugse
Agar wood 6 Yes 3 2 33.3 No 0 0 – No 0 0 –
Amber 4 Yes 1 0 0.0 No 0 0 – No 0 0 –
Amber oil 1 No 0 0 – Yes 1 1 100.0 No 0 0 –
Balsam of 
Mecca
1 No 0 0 – No 0 0 – No 0 0 –
Bitter almond 
gum
1 Yes 4 1 100.0 No 0 0 – No 0 0 –
Cedar tar 3 No 0 0 – No 0 0 – No 0 0 –
Cherry gum 5 Yes 5 5 100.0 No 0 0 – No 0 0 –
Cypress tar 1 No 0 0 – No 0 0 – No 0 0 –
Frankincense 8 Yes 4 3 37.5 Yes 3 2 25.0 Yes 2 2 25.0
Galbanum 1 Yes 7 1 100.0 Yes 4 1 100.0 Yes 3 0 0.0
Gum arabic 1 Yes 2 1 100.0 Yes 1 0 0.0 Yes 2 1 100.0
Ladanum 3 Yes 7 3 100.0 Yes 3 2 66.7 No 0 0 –
Mastic 10 Yes 6 6 60.0 Yes 3 3 30.0 Yes 1 1 10.0
Myrrh 8 Yes 9 7 87.5 Yes 6 5 62.5 Yes 4 3 37.5
Olive resin 2 Yes 5 2 100.0 No 0 0 – No 0 0 –
Pine resins 7 Yes 5 4 57.1 Yes 4 3 42.9 No 0 0 –
Pine tar 4 Yes 6 3 75.0 Yes 2 2 50.0 Yes 2 2 50.0
Pine 
turpentine oil
4 No 0 0 – Yes 7 3 75.0 Yes 2 2 50.0
Plum gum 1 Yes 2 1 100.0 No 0 0 – No 0 0 –
Scammony 4 Yes 6 2 50.0 Yes 3 1 25.0 No 0 0 –
Storax, liquid 
(exotic)
4 No 0 0 – Yes 2 1 25.0 Yes 3 2 50.0
Storax, liquid 
(local) 
1 No 0 0 – Yes 2 1 100.0 Yes 3 1 100.0
Storax, solid 4 Yes 4 1 25.0 No 0 0 – No 0 0 –
Sumatra/siam 
benzoin
4 No 0 0 – Yes 4 1 25.0 Yes 3 2 50.0
Terebinth resin 4 Yes 5 4 100.0 Yes 1 1 25.0 No 0 0 –
Venice 
turpentine
1 Yes 1 0 0.0 Yes 1 0 0.0 Yes 3 0 0.0
93 82 46 47 27 28 16
aSubstances used medicinally in the iatrosophia.
bTotal number of use groups (UGs) treated by the medicinal uses of the respective text(s).
cIndicates if a substances is included for medicinal purposes in the respective text(s).
dNumber of UGs included in the iatrosophia which are also found in the respective text(s).
ePercentage of UGs included in the iatrosophia which are also found in the respective text(s).
of toxicological concerns (e.g., oil of turpentine, scammony) or 
potential allergic reactions (e.g., crude turpentine, colophony; 
Williamson, 2003; Blaschek et al., 2007). On the other hand new 
indications of ancient drugs with a long tradition have found 
their way into modern phytotherapy as illustrated by the gastro-
intestinal and musculo-sceletal uses of Indian frankincense or the 
gastrointestinal uses of gum Arabic (Williamson, 2003; Blaschek 
et al., 2007; ESCOP, 2009).
comparIson of tHe sImple remedIes to etHnomedIcal and 
bIoactIvIty data
The great majority of the medicinal URs concerned plant uses 
listed in compound remedies. Overall 17 simple remedies (14.4%) 
were counted, they involved 23 medicinal URs (10.7%) with 12 
different substances. In Table 5 the simple remedies are presented 
together with their deduced pharmacological functions. The results 
of the cross-referencing to reported biological activities are shown 
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Table 5 | Simple remedies in the iatrosophia: interpretation of the mentioned use and deduced pharmacological functions.
Recipea Substanceb Mentioned usec Form of 
Administr.d
interpretatione Deduced pharmacological 
functionsf
IM 14.3 Agar wood, benzoin, 
or, solid storax
Fracture of the head Filling for the 
fracture
Open cranial fracture Anti-inflammatory
Antimicrobial
Wound healing promotion
IM 63.03 Agar wood, benzoin, 
or solid storax
Podalgia Beverage Gout and rheumatic 
conditions (incl. arthritis, 
athrosis)
Analgesic
Anti-inflammatory
Immunomodulatory
GP PME 01 Cherry gum It relieves the cough but also 
the liver, it helps the eyesight 
and makes your face look 
bright.
Beverage Productive or dry cough Antitussive
Bronchodilatating
Expectorant
Liver health Beneficial effect on liver diseases
Vision improvement Vision improving effects
Healthy and bright 
complexion 
Beneficial effect on liver or kidney 
diseases
GP PME 02 Cherry gum Beneficial in stones Beverage Gall, kidney or bladder 
stones
Stone-dissolving/-expelling
GP ΡΞΓ 02 Frankincense Every kind of rheumatism Ointment Rheumatic conditions Analgesic
Anti-inflammatory
Immunomodulatory
IM 134.05 Galbanum If the child dies in her [the 
mother’s] belly
Beverage Abortion of a dead fetus Abortive
Antispasmodic
GP PMH.05 Gum arabic Concerning the flux of the belly Snack or 
beverage
Diarrhea Antibiotic
Anti-inflammatory
Antimotility
Antisecretory
Bulk-forming effect
IM 48.02 Ladanum Hemorrhoids and spots inside 
and outside of the anus
Poultice Hemorrhoids 
accompanied by anal 
excema
Analgesic
Anti-inflammatory
Antimicrobial
IM 128.03 Ladanum To stop hair loss Fumigation Alopecia Antifungal
Beneficial effects on hair cycle
5-Alpha-reductase inhibition
IM 64.02 Pine resin Rheumatic diseases and 
podalgia
Poultice Rheumatic conditions 
and gout
Analgesic
Anti-inflammatory
Immunomodulatory
GP PKΘ 06 Plum gum It dissolves the stones of 
dysuria
Beverage Gall, kidney or bladder 
stones, dysuria
Antibiotic
Stone-dissolving/-expelling
IM 41.05 Scammony It purges “depositions and 
poisons,” keeps off fevers, 
shivers, quartan fevers.
Beverage Cathartic, prophylactic 
against fevers including 
malaria
Antibacterial
Antimalarial
Antiviral
Cathartic
IM 89.03 Terebinth resin Old ulcers Poultice Infected ulcerative 
wounds
Anti-inflammatory
Antimicrobial
IM 137.05 Terebinth resin Diarrhea in small children Fumigation Diarrhea in infants Antibiotic
Anti-inflammatory
Antimotility
Antisecretory 
(Continued)
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is used as a vulnerary agent to protect and disinfect the skin 
(Williamson, 2003). Depending on quality and origin, 70–80% 
of Sumatra benzoin consist of free benzoic and cinnamic acids 
and their corresponding esters. Free benzoic acid (up to 20%), 
its esters (70–95%) and the triterpene α-siaresinolic acid (6%) 
are the main constituents of Siam benzoin (Blaschek et al., 
2007). Benzoic acid is conventionally used as a preservative by 
the food industry due to its antimicrobial activity. Mycopol®, a 
preparation containing benzoic acid beside other active com-
pounds has a long history of use in the treatment of fungal 
skin infections and is beneficial in a large number of patients 
(Steppert, 1966). Preparations of the balsams from S. benzoin 
and S. tonkinensis were studied for their phagocytotic activity 
in mice inoculated with E. coli. The 95% ethanolic extract of 
the latter species and the insaponifiable fractions of both spe-
cies showed to protect at least four of five animals (50 mg/kg, 
intraperitoneally; Delaveau et al., 1980).
(iii) Although Dioscorides listed various indications for solid 
storax (Berendes, 1902, 1.79, styrax) and Paulus Aegineta 
employed it in many remedies (Adams, 1844/1846/1847), 
no relationship between these ancient uses and those descri-
bed in the two iatrosophia recipes presented above could be 
found. Phytochemical or pharmacological properties of solid 
storax have not been explored so far.
Cherry gum – prunus avium
According to recipe PME 01 in the Geoponikon (GP PME 01) drink-
ing every morning cherry gum dissolved in water should relieve 
cough, improve liver health and vision as well as “make the face 
look bright.” While in GP PME 02 the gum dissolved in wine is 
recommended in stones. Looking at Dioscorides’ account on the 
gum (Berendes, 1902, 1.157) reveals that the iatrosophia appear to 
have borrowed from this reference. Paulus Aegineta, too, mentioned 
the above recipe for stone affections and the gum’s ability to ease 
“asperities of the trachea” (Adams, 1844/1846/1847, 7.3, 167).
IM 149.03 Terebinth resin For those who cannot urinate Snack Impaired urination 
possibly related to 
bladder stones, urinary 
tract infections, BPH or 
prostate cancer 
Alpha-receptor antagonistic effect
5-Alpha-reductase inhibition
Antibiotic
Anticancer
Stone-dissolving/-expelling
KI 9.01 Terebinth resin Deep wounds that need a 
filling
Ointment Incisions caused by 
sharp or cutting 
implements
Analgesic
Antimicrobial
Wound healing promotion
KI 10.01 Terebinth resin Pestilent ulcers and foul ulcers Ointment Infected ulcerative or 
malignant wounds
Anticancer
Anti-inflammatory
Antimicrobial
aSignature of the recipe, the first two capitals indicate the respective text (see Table 1).
bCorresponding to the homonymous column in Table 3.
cUses were translated by retaining the original wording as far as possible.
dOral applications: beverage, snack; Topical applications: filling, fumigation, ointment, poultice.
eThe mentioned uses were interpreted as described in 2.2.1.
fThe deduction of the pharmacological functions was conducted as described in 2.2.6.
Table 5 | Continued
Recipea Substanceb Mentioned usec Form of 
Administr.d
interpretatione Deduced pharmacological 
functionsf
in Table 6. In the following sections for each substance the simple 
remedies are first compared to relevant ethnomedical data and then 
the reported biological activities as listed in Table 6 are reviewed. 
Here, we primarily considered studies that were conducted with the 
respective substance (including full extracts or fractions). Studies 
that solely investigated isolated compounds or another plant part 
of the same or a closely related species were included mainly if no 
other data were available but then only if they stood in relationship 
to the respective substance. In Section “Evaluation of the Reported 
Bioactivity Data” the results of the comparison to the bioactivity 
data are evaluated.
(i) agar wood – aquilaria spp. and other thymelaeaceae, (ii) benzoin – s. 
benzoin, s. paralleloneurum, s. tonkinensis, or (iii) solid storax – s. 
officinalis
In the third recipe on page 14 of the Iatrosophikon of Mitrophanous 
(recipe IM 14.03) pounded “píssa tou xylalá” is applied on an open 
fracture of the cranial bone obviously to protect the injury and 
promote healing. In IM 63.03 the pounded substance is dissolved in 
rum and then extracted in the sun for 8 days, the resulting “tincture” 
is drunk as a remedy against podalgia. The name “píssa tou xylalá” 
can be attributed to all of the above three substances (i, ii, iii).
(i) Both Dioscorides (Berendes, 1902, 1.21) and Paulus Aegineta 
(Adams, 1844/1846/1847, 7.3, 18) discussed agar wood 
by the name of agallochon without, however, mentioning 
any uses related to the above recipes. In a series of in vitro 
tests a 70% ethanolic extract from powdered agar wood 
of Aquilaria sinensis showed anti-inflammatory proper-
ties (Yam, 2007, pp. 81–88). The extract had no inhibitory 
effect on cyclooxygenase activity but specifically reduced 
5-lipoxygenase activity with an IC
50
 value around 30 μg/ml.
(ii) As in the case of Dioscorides, none of the drugs discussed by 
Paulus Aegineta seems to refer to benzoin. Today, Sumatra 
benzoin is known as an ingredient in Friar’s Balsam which 
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Table 6 | Cross-referencing of deduced pharmacological functions to reported biological activities.
Substancea Deduced pharmacological 
functionsb
Matching biological activities reported in the studiesc Study typed Stud.e
Agar wood Analgesic Anti-inflammatory, 1× In vitro 1
Anti-inflammatory
Antimicrobial
Immunomodulatory
Wound healing promotion
Cherry gum Antitussive [Indirect hepatoprotective, 1×] in vivo1 2
Beneficial effect on liver or kidney 
diseases
[Improved metabolic profile in chronic renal failure, 1×] In vivo1
Bronchodilatating
Expectorant
Stone-dissolving/-expelling
Vision improving effects
Frankincense Analgesic Anti-inflammatory, 3× In vitro, in vivo 3
Anti-inflammatory Decrease of cytokine levels (immunomodulatory), 1× In vivo
Immunomodulatory
Galbanum Abortifacient Spasmolytic In vitro 1
Effects on uterine contractility
Gum arabic Antibiotic Improved recovery rates from diarrhea, 1× In vivo 4
Anti-inflammatory Proabsorptive (antisecretory), 2× In vivo
Antimotility No significant antidiarrheal effects, 1× Clinical2
Antisecretory
Bulk-forming effect
Ladanum Analgesic Antibacterial, 2× In vitro 4
Antifungal Antioxidant (anti-inflammatory), 1× In vitro3
Anti-inflammatory No significant anti-inflammatory effect, 2× In vitro3, in vivo4
Antimicrobial
Effects with a beneficial action
on the hair cycle
5-Alpha-reductase inhibition
Pine resin Analgesic Analgesic, 1× In vivo 3
Anti-inflammatory Anti-inflammatory, 2× In vivo4, in vivo3
Immunomodulatory
Plum gum Antibiotic No data available – 0
Stone-dissolving/-expelling
Scammony Antibiotic Antibacterial (antibiotic), 1× In vitro4 1
Antimalarial
Antiviral
Cathartic 
Solid storax Analgesic No data available – 0
Anti-inflammatory
Antimicrobial
Immunomodulatory
Wound healing promotion
Sumatra or Siam 
benzoin
Analgesic Antifungal, 1× Case reports2,4 2
(Continued)
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Anti-inflammatory Phagocytotic (antibacterial), 1× In vivo
Antimicrobial
Immunomodulatory
Wound healing promotion
Terebinth resin Alpha-receptor antagonistic effect Antibacterial, 1× In vitro4 7
Analgesic Antimicrobial (antibiotic), 1× In vitro
Antibiotic Anti-hypernociceptive (analgesic), 1× In vivo4
Anticancer Anti-inflammatory, 3× In vivo4, in vivo3
Anti-inflammatory Inhibition of LDL oxidation (anti-inflammatory), 1× In vitro
Antimicrobial Leucotriene inhibition (anti-inflammatory), 1× In vitro4
Antimotility
Antisecretory
Wound healing promotion
5-Alpha-reductase inhibition
aCorresponding to the homonymous column in Table 5.
bCorresponding to the homonymous column in Table 5. All pharmacological functions referring to the same substance were consolidated.
cWhere appropriate the deduced pharmacological function to which the reported activity was cross-references is added in parenthesis. Activities in squared brackets 
refer to studies conducted with an analogous substance from a taxonomically unrelated species (see footnote 4). The figure indicates the number of studies reporting 
the corresponding activity.
cType of the study reporting the corresponding activity.
dNumber of studies included in the comparison.
The study was conducted with: 1gum arabic, 2a compound preparation that included additional further active constituents, 3a different plant part, 4isolated compounds only..
Table 6 | Continued
Substancea Deduced pharmacological 
functionsb
Matching biological activities reported in the studiesc Study typed Stud.e
The symptoms listed in GP PME 01 could be related to a defined 
disease of some specific organ or, in their entirety, a complex systemic 
disease or even intoxication. While cherry gum can hardly boast of 
bioactivity data, another natural gum typically composed of sugar 
polymers is comparatively well explored. Namely, for gum Arabic a 
number of the actions have been suggested which are related to some 
of the pharmacological functions deduced from the above recipes. In 
Sudan, the gum is prescribed in chronic renal failure (CRF) due to 
its ability to decrease uremia levels or reduce the frequency of dialy-
sis. In a preliminary study involving 36 CRF patients, a significant 
improvement of the metabolic profile could be observed in the groups 
receiving 50 g gum Arabic daily in comparison to baseline and control 
(Ali et al., 2008). Although gum Arabic seems to lack a direct hepato-
protective action, 100 mg administered intraperitoneally suppressed 
macrophage activation and attenuated the extent of liver injury in a 
rat model of induced hepatic necrosis (Mochida et al., 1996).
Frankincense – Boswellia sacra, B. bhau-dajiana, B. carteri, B. 
frereana, B. papyrifera
In recipe GP PΞΓ 02 an ointment containing frankincense, pig fat, 
and egg white was prepared for the topical treatment of “every kind 
of rheumatism.” The Roman encyclopedist Celsus (ca. 25 BCE – 50 
CE), wrote that frankincense was beneficial in the treatment of gout 
(Martinez et al., 1989) and Paulus Aegineta applied it in a powder-
mix for the same condition (Adams, 1844/1846/1847, 7.13, 539).
The majority of studies conducted with Boswellia resins refer 
to Indian frankincense from B. serrata, which according to the 
ESCOP monographis indicated for “relief of painful osteoarthritis” 
or “treatment of inflammatory bowel disease.” Numerous studies 
have been conducted both with the resin and its constituents, they 
suggest among others anti-inflammatory and immunomodulatory 
activities (ESCOP, 2009). Some of these data are based on boswel-
lic acids. These pentacyclic triterpenic acids are characteristic for 
Boswellia resins including those from African or Arabian species 
and, therefore, relevant in the context of the above iatrosophia 
remedy. In fact, studies reviewed by Moussaieff and Mechoulam 
(2009) showed the potential of these compounds in animal models 
of arthritic conditions.
However, studies actually conducted with the resin of African or 
Arabian Boswellia species are limited. One of these studies investi-
gated the anti-inflammatory activity of extract fractions and trit-
erpene acids isolated from the resin of B. carteri in TPA-induced 
ear edema in mice. Topically applied hexane- and EtOAc-soluble 
fractions (1.0 mg/ear) exhibited potent inhibitory activities (91–
94% inhibition, p < 0.01 significant from control). Isolated di- 
and triterpenes, with the exception of incensole acetate, exhibited 
marked anti-inflammatory activities (ID
50
 values of 0.05–0.49 mg/
ear). Some of the compounds were equally or more active than the 
positive controls hydrocortisone (ID
50
 0.03 mg/ear) or indometha-
cine (ID
50
 0.3 mg/ear) respectively (Banno et al., 2006). The resin 
of B. carteri (B. carterii) was also investigated for its potential to 
influence adjuvant-induced arthritis in rats. The tested acetone 
extract administered intragastrally at a dose of 0.9 g/kg (average 
body weight: 224.63 g) significantly suppressed arthritic scores, 
attenuated paw edema and decreased cytokine levels (TNF-α, 
IL-1 β), compared to control (Fan et al., 2005).
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rats recovering from diarrhea induced by cathartic agents gained 
more weight and had lower fecal output when additionally supple-
mented with the gum (Teichberg et al., 1999). In general, the in vivo 
data suggest a potential benefit of gum Arabic in the context of diar-
rhea and malabsorption caused by infection or intestinal dysfunction.
In a multicenter randomized placebo controlled study 144 boys 
aged 1–36 months suffering from diarrhea received an oral rehy-
dration solution with or without a mixture containing 9% gum 
Arabic in addition to other non-digestible carbohydrates. However, 
since no significant group differences in stool volume, duration of 
diarrhea, duration of hospital stay and need of intravenous rehy-
dration could be observed, the mixture was considered ineffective 
(Hoekstra et al., 2004).
Ladanum – Cistus incanus subsp. creticus
To heal hemorrhoids accompanied by an anal eczema, 10 dr (drámi) 
ladanum were heated in 4 dr olive oil, spread on a piece of cloth and 
applied as a poultice on the affected area. This treatment should 
be continued for 8 days (IM 48.02). According to recipe IM 128.03 
exposing the scalp to smoke of ladanum would stop hair loss. In 
fact, Ladanum was used to treat hair loss by Dioscorides (Berendes, 
1902, 1.128) as well as by Paulus Aegineta (Adams, 1844/1846/1847, 
3.1.5/8, 339 and 7.3.11, 208). While both of them knew of its 
applications in liniments or plasters (Adams, 1844/1846/1847, 
7.18.8, 578; Berendes, 1902, 1.128), in particular the latter author 
made specific reference to abscesses, furuncles, or ulcers (Adams, 
1844/1846/1847, 4.34.2, 94–95 and 4.39.1, 103). (for synonyms see 
Inventory of Resins and Gums and Table 3)
While no data are available regarding alopecia, a number of 
studies investigated potential actions of the Cistus resinor its 
compounds that could be of relevance in the treatment of hemor-
rhoids or eczema. Ladanum from C. creticus subsp. creticus exerted 
only a weak antibacterial activity against Staphylococcus aureus, 
S. epidermidis, and S. hominis (MIC 2 mg/ml; Demetzos et al., 
1999), although its chloroform–methanolic extract showed some 
inhibitory activity against several bacteria (Acinetobacter anitra-
tus, Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, 
Proteus mirabilis, Pseudomonas aeruginosa, S. aureus; Kalpoutzakis 
et al., 1998). Isolated sclareol and another labdane type diterpene 
inhibited the growth of the three tested Staphylococcus germs with 
a MIC of 0.1 mg/ml which is 100-fold lower than streptomycin 
(Demetzos et al., 1999).
Because ladanum is exuded from the glandular hairs of stem 
and leaf (Hadjikyriakou, 2007, p. 174), bioactivity data on lipo-
philic compounds of the leaves or corresponding lipophilic extracts 
should not be disregarded; Pure ethanolic extracts of C. incanus 
subsp. tauricus and C. aff. creticus at a dose of 10 μg/ml showed an 
antioxidant effects with TEAC values of 3.6 and 2.5, respectively 
(Trolox: IC
50
 = 0.63 ± 0.02 μg/ml). However, no significant inhibi-
tion of the tested inflammatory parameters (IL-6, IL-1β, TNF-α, 
PGE
2
, NF-κB) could be shown (Taila et al., 2008). Similarly, in an 
anti-inflammatory model, no significant effect on the skin barrier 
repair could be observed with two labdane diterpenes from the 
leaves of C. creticus subsp. eriocephalus (Viv.) Greuter and Burdet 
which were applied on the back of hairless mice (5% solution, 
25 μl/cm3) previously exposed to UV-B irradiation (Demetzos 
et al., 2001).
In an in vitro model of osteoarthritis, 100 μg/ml of an absolute 
ethanol extract from the resin of B. frereana (the dose was selected 
as a result of a dose response study on isolated articular chondro-
cytes) showed a protective effect against cartilage loss by inhibiting 
breakdown of the collagenous matrix mainly through inhibition 
of pro-inflammatory mediators (Blain et al., 2010).
Galbanum – Ferula gummosa, F. kokanika, F. schair, F. rubricaulis
According to recipe IM 134.05 drinking pounded galbanum in 
water will expel a dead embryo/fetus. The same use was men-
tioned by the authors of “On the Diseases of Women,” one 
of the Hippocratic treatises (Riddle, 1992), by Dioscorides 
(Berendes, 1902: 3.87(97)) as well as by Paulus Aegineta (Adams, 
1844/1846/1847, 3.61, 611).
The use of uterine stimulating herbs during pregnancy is 
regarded as a potential risk factor for a spontaneous abortion 
(Johns and Sibeko, 2003). Although the ancient use might sug-
gest to place galbanum among these herbs, no studies reporting 
contractile effects on the uterus are available. Based on its tradi-
tional use in the treatment of diarrhea, Sadraei et al. (2001) instead 
investigated the spasmolytic effects of essential oil and extracts of 
the gum resin from Ferula gummosa on the contraction of iso-
lated rat ileum. Ether, petrol and methanol extracts inhibited the 
contractions induced by 80 mM KCl most potently (IC
50
 values: 
0.55, 1.4, and 7.5 μg/ml, respectively). Etheric or petrolic extracts 
attenuated the maximum attainable response of ACh with IC
50
 
values of 10 or 5.1 μg/ml, respectively. The authors argued that at 
least part of the inhibitory effect was due to α- and β-pinene, two 
common constituents of the essential oil, ether, and petrol extracts. 
As shown in a study with the essential oil of Bupleurum fruticosum 
L., another Apiaceae, fractions containing substantial amounts of 
these two monoterpenes are able to exert antispasmodic effects on 
the uterus of the rat (Lorente et al., 1989). While this points to some 
possibly relevant effects, no direct evidence for the induction of 
labor or abortion exists for galbanum. Perhaps the iatrosophia use 
of galbanum should not be linked to a later stage of pregnancy as 
purported by the wording of the above recipe but rather to earlier 
stages or fertility control in general. Rosemary (Rosmarinus offici-
nalis L., Lamiaceae), for example, has known antispasmodic in vivo 
effects on the uterus and is used in tea mixtures for fertility control 
in Central America (Lemonica et al. (1996).
Gum arabic – acacia senegal, a. seyal, a. nilotica
The gum ingested with old wine and some food is said to be a 
remedy in diarrhea (GP PMH 05). Dioscorides in discussing aka-
kia, used the juice of the pods to “bind a loose belly” and was also 
acquainted with the astringent properties of the gum (Berendes, 
1902, 1.133). Paulus Aegineta was mixing akakia with other herbs 
for the treatment of dysentery (Adams, 1844/1846/1847, 7.12, 
530–531, 534–535). Finally, the gum has been reported as a dysen-
tery remedy from Senegal (Watt and Breyer-Brandwijk, 1962, cited 
in Maiga et al., 2005).
Published studies on biological effects of the gum have been 
reviewed in detail by Ali et al. (2009). In particular the effects on the 
gastrointestinal tract were rated positively; Gum Arabic improved 
small intestinal absorption of sodium and water in two rat models of 
induced diarrhea (Wapnir et al., 1997; Codipilly et al., 2006). Other 
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(cf. 3.4.2), was already mentioned by Dioscorides (Berendes, 1902, 
1.175) and again by Paulus Aegineta (Adams, 1844/1846/1847, 7.3, 
180). From the villages of Cyprus plum gum was reported as a 
tonic, laxative, and vermifuge in substitution of more expensive 
gums (Arnold-Apostolides, 1985). No bioactivity data were avail-
able for this exudate.
scammony – Convolvulus scammonia
In IM 41.05 a drink is prepared by mixing 1/3 dr scammony and 1 dr 
of sugar in some water. This remedy would purge easily expelling 
all “depositions and poisons.” Repeating the therapy after 1 month 
would keep off “fevers, shivers, and quartan fevers” (malaria 
caused by Plasmodium malariae) for the rest of the year. Although 
Dioscorides was well acquainted with the purgative effects of scam-
mony [Berendes, 1902, 1.168(171)] and Paulus Aegineta applied 
the drug in numerous simple and compound remedies for this 
purpose (Adams, 1844/1846/1847, 7.3, 341 and 7.4, 481), neither of 
them mentioned fever or malaria. Unlike these two, the physician 
Alexander of Tralles from Lydia in Asia Minor, who wrote in the 
sixth century, highlighted the usefulness of scammony in “quartan” 
and other fevers linking their cause to excessive “bile and phlegm” 
(Puschmann, 1878/1879, p. 1.384).
Beside Convolvulus scammonia, several other species of the 
Apocynaceae and Convolvulaceae provide some sort of scam-
mony, the resinous exudates obtained from the root. Mexican 
scammony, for example, is obtained from Ipomoea orizabensis (G. 
Pelletin) Ledeb. ex Steud., Convolvulaceae. This and the former 
species are recognized to act as laxatives or drastic purgatives due 
to the resin glycosides present in the exudate (Williamson, 2003; 
Blaschek et al., 2007). A number of these resin glycosides includ-
ing scammonins isolated from Ipomoea tricolor and I. orizabensis 
were tested against different S. aureus strains. Synergistic effects 
between these compounds were observed, revealing direct bacte-
ricidal (MIC values 4–32 μg/ml compared to 0.25 and 64 μg/ml for 
tetracyclin), resistance disabling or antibiotic potentiating effects 
(Pereda-Miranda et al., 2006). However, studies investigating the 
potential of scammony or its compounds against malaria causing 
pathogens (Plasmodium spp.) are lacking.
terebinth resin – pistacia atlantica (p. terebinthus)
In recipes KI 9.01/10.01 and IM 89.03 terebinth resin was pounded, 
mixed with egg yolk and used as a ointment or applied in a poul-
tice for the treatment of infected, ulcerative, or malignant wounds 
and deep cuts. To ease urination problems the pounded resin was 
spread on a piece of bread and eaten (IM 149.03). The latter use 
could be related to bladder stones, some infection, prostate hyper-
plasia or cancer. Dioscorides in referring to all resins highlighted 
their diuretic properties, their use in leprosy or in plasters, poul-
tices, and ointments (Berendes, 1902, 1.91). Paulus of Aegina was 
making copious use of (re¯tine¯) terebinthine¯ in topical applications 
such as plasters or ointments for abscesses, swellings, foul, and 
spreading ulcers or phagedena (Adams, 1844/1846/1847, 4.41, 4.44, 
7.17–7.20). Several references from the Roman Antiquity and the 
European Renaissance to early modern periods mention the use 
of the terebinth resin to treat various cancers, tumors, carcinomas 
and indurations (Hartwell, 1967). Recent accounts on the use of 
resin from P. atlantica are equally limited as such for P. terebinthus. 
pine resin – pinus brutia, p. halepensis, p. nigra subsp. pallasiana
For the therapy of rheumatic conditions and podalgia a poul-
tice is prepared using píssa mávri (IM 64.2). This name denotes 
cooked resin known as resina nigra (Table 2), the dark-colored 
quality of rosin (Richter, 1827). The pounded substance is dis-
solved in hot barley gruel, the mass is then spread on a piece 
of cloth of the size of the affected area be it the knee, ankle, or 
hand. Dioscorides mentioned that one of the properties com-
mon to all resins was their warming effect (1.91), in particular 
“burnt” resin was used in plasters or ointments (1.93; Berendes, 
1902). Paulus Aegineta mentioned poultices containing “turpen-
tine” for the treatment of rheumatic diseases and gout (Adams, 
1844/1846/1847, 3.78, 663, 665). Arnold-Apostolides (1985) 
recorded several medicinal uses of topical applications of resin 
and tar from P. brutia, P. nigra ssp. pallasiana, and P. halepensis 
from various places in Cyprus. Similar uses and applications 
were also reported in another ethnobotanical study conducted 
in western Anatolia (Turkey) for the resin from P. nigra ssp. pal-
lasiana and P. brutia (Honda et al., 1996).
These poultices act as a rubefacients, irritants, and counter-
irritants. They certainly will achieve an increase of blood flow in 
the area of application, which may favor the absorption of anti-
inflammatory secondary metabolites. In this context, an ethyl 
alcohol extract of turpentine (crude pine resin) from Pinus nigra 
ssp. pallasiana showed an in vivo anti-nociceptive effect when 
administered internally thus supporting the existence of such 
active principles. The extract revealed a dose-dependent analgesic 
effect in a writhing response in mice induced by acetic acid at a 
dose of 25 mg/kg. Metamizol at 200 mg/kg and the resin extract 
at 50 mg/kg showed a comparable effect (Gülçin et al., 2003). 
However, the pharmacological effects of topically applied prepara-
tions can only be of any relevance in arthritic inflammations if the 
active principle is able to penetrate the skin. In fact, certain of the 
possibly involved compounds show a topical bioavailability and 
suggest direct anti-inflammatory effects. The diterpene abietic 
acid, for example, is one of the major compounds in the non-
volatile fraction of the resin of P. brutia (Gören et al., 2010). In 
a TPA-induced mouse ear edema model topically applied abietic 
acid inhibited the development of swelling in a significant and 
dose-dependent manner. The highest dose (1 mg/ear) showed 
an inhibitory effect of 74.8% being in the similar range as the 
effect of indomethacin (0.5 mg/ear, inhibitory effect approx. 90%; 
Fernández et al., 2001).
Another study investigated the in vivo anti-inflammatory activity 
of an ethyl-acetate extract from the bark of P. brutia in comparison 
to Pycnogenol®, a standardized bark extract of French maritime pine 
Pinus maritima Lam. In the carrageenan induced rat paw edema 
model the intraperitoneal administration of each of the preparations 
inhibited paw-swelling dose-dependently exhibiting significant anti-
inflammatory activities at doses of 75 and 100 mg/kg. At these doses 
P. brutia extract also showed a significantly stronger activity than 
10 mg/kg of indomethacin (Ince et al., 2009).
plum gum – prunus domestica
According to GP PKΘ 06 drinking plum gum dissolved in red wine 
also dissolves the “stones of dysuria.” This recipe, obviously related 
to the doctrine of signatures and an alternative of GP PME 02 
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One report from Iraq documents that resin from Pistacia trees 
(P. atlantica Desf. and P. khinjuk Stocks in Hook.) was applied as 
an antiseptic to wounds by local inhabitants (Guest and Al-Rawi, 
1966, p. 107). Another recipe (IM 137.05) recommends exposing an 
infant to the smoke of terebinth resin to stop diarrhea. Medicinal 
smokes are popular in many cultures; the treatment of diarrhea by 
smoke inhalation has also been reported from Guyana and North 
America for leaves and stems of two members of the Lauraceae but 
the understanding of the pharmacodynamics of medicinal smokes 
is limited (Ben Amar, 2006).
Bioactivity studies investigating the resin of P. atlantica are lack-
ing and quantitative analytical data are restricted to the volatile 
fraction. The crude oleo resin is rich in essential oil, 32.6% were 
measured in samples from Morocco with α-pinene accounting for 
42.9% (Barrero et al., 2005). Corresponding figures for the variety 
P. atlantica var. mutica were 22.0 and 70.0%, respectively (Delazar 
et al., 2004). Different qualities of essential oil of the resin from P. 
atlantica were tested for their antimicrobial potential against seven 
bacteria (E. coli, E. cloacae, K. pneumoniae, Xanthomonas maltophilia, 
P. aeruginosa, Enterococcus faecalis, S. aureus) and three different 
strains of C. albicans. The MIC for the Gram-positive and Gram-
negative bacteria were ≤10 and 102 μg/ml, respectively, and for C. 
albicans between 103 and 1 mg/ml (Benabderrahmane et al., 2009).
Alpha-pinene isolated from the turpentine oil of Pinus pinaster 
Aiton exhibited a distinctive bioactivity against various isolates 
of Actinomadura madurae with MICs ranging between 3.3 and 
5.0 μl/ml (positive control streptomycin: 29.8–50.0 μl/ml) and 
a minimum microbicidal concentration (MMC) of 10.0 μl/ml 
(streptomycin: 50.0–75.0 μl/ml). This pathogen is the main cause 
of actinomycetoma, an infectious skin disease which is able to 
eventually form a tumor and cause problematic secondary infec-
tions (Stojkovic et al., 2008). The same monoterpene compound 
isolated from the essential oil of Ugni myricoides (Kunth) O. Berg, 
Myrtaceae, was investigated for its anti-hypernociceptive potential 
in a model of neuropathic pain of the sciatic nerve in mice. Alpha-
pinene orally applied at doses of 25 and 50 mg/kg was capable of 
abolishing the hypernociceptive response with inhibitions of 64 
and 89%, respectively. This effect was comparable to gabapentin, 
a drug clinically used to treat neuropathic pain (70 mg/kg, orally 
applied: inhibition of 88%; Quintão et al., 2010).
The potential of resin extracts from P. terebinthus L. var. chia 
to protect LDL from oxidation was dependent on the polarity of 
the solvent and ranged between 27.0 and 49.5%. A corresponding 
extract from Chios mastic gum (P. lentiscus L. var. chia) showed a 
distinctly higher protection rate sometimes more than doubling the 
one achieved with the terebinth resin (Andrikopoulos et al., 2003).
Anti-inflammatory and anti-phospholipase A
2
 activities of a 
methanolic extract from P. terebinthus L. galls were investigated in 
a number of animal models. In TPA- or EEP-induced mouse ear 
edema models topically applied extract (1 mg/ear) revealed a 58 
or 44%, respectively, inhibition of chronic inflammatory swelling. 
Orally applied extract (200 mg/kg) inhibited paw edema induced 
by PLA
2
 from two different types of venoms by 48–67% (Giner-
Larza et al., 2000). In partially identical mouse models the same 
group tested four different triterpenes from P. terebinthus L. galls 
administered in concentrations between 0.3 and 1 mg/kg topically 
and 30 mg/kg intraperitoneally (Giner-Larza et al., 2001 and 2002). 
Two isoforms, masticadienonic acid and masticadienolic acid, were 
also found in turpentine resin (Blaschek et al., 2007). They both 
showed significant inhibitory activities in ear and paw edemas. 
The latter additionally inhibited leukotriene B
4
 production in rat 
polymorphonuclear leukocytes with an IC
50
 of 16.6 μM (apigenin 
IC
50
 of 13 μM; Giner-Larza et al., 2002).
Evaluation of the reported bioactivity data
Altogether 28 studies were included in this comparison (Table 6). 
Although several further studies were found in the literature search, 
the unusual high concentrations of the test samples applied in the 
respective assays eventually questioned the significance of the sug-
gested biological activities and made us abstain from including 
them. Similar observations were made by Adams et al. (2009) when 
discussing the results of bioscientific studies in relationship to the 
uses described in the European Renaissance herbals. This problem 
was addressed by Gertsch (2009) in a commentary regarding the 
interpretation of molecular pharmacological data in ethnopharma-
cological publications. The author argued that much of the problem 
is related to a misemployment of the concentration-effect paradigm 
and the overinterpretation of in vitro data.
The comparison of the deduced pharmacological functions with 
matching biological activities reported in the literature revealed an 
overall fragmentary picture in terms of the available data (Table 6). 
While for cherry gum (Prunus avium) no matching data were 
found, plum gum (Prunus domestica), solid storax (S. officinalis) 
and, apart from its essential oil, terebinth resin from P. atlantica do 
not appear to have been explored at all. For the remaining 9 of the 
12 substances, which to a certain extent have been the subject of 
medicinal or pharmacological research, one or more studies were 
available that reported some sort of matching effects. Frankincese, 
gum Arabic and pine resin had corresponding bioactivity data for 
at least half of the deduced pharmacological functions. The major-
ity of the associated data were linked to studies including mainly 
in vitro (11) and animal models (14) only two studies included 
data from patients. In several of these models, however, isolated 
compounds, extracts from other plant parts or compound prepa-
rations and not the substance mixture were tested. Some of the 
studies referring to gum Arabic, ladanum, and turpentine resin also 
reported inactivity, weak, or non-significant effects. Nevertheless, in 
the great majority of the cases the available studies reported positive 
results. At least four cases have appropriate data available which 
allows to draw direct conclusions on the putative pharmacological 
effectiveness of the respective substance, because the associated in 
vivo studies were actually conducted with the plant exudate or its 
full extract and showed meaningful results; For the iatrosophia use 
of pine resin in rheumatic conditions and podalgia corresponding 
evidence is available demonstrating the analgesic potential of a 
crude resin extract from P. nigra subsp. pallasiana. Moreover, both 
from other historical texts as well as ethnobotanical studies various 
topical applications of pine resins were reported. Overlapping uses 
with ethnobotanical data “can lend strength and credibility to a 
lead which originated from a historical text” (Hunt, 1996, p. 92). 
Ethnomedical uses supporting the findings of animal studies were 
reported too for applications of gum Arabic as a diarrhea remedy, 
frankincense from Boswellia carteri in the treatment of rheumatic 
diseases and Sumatra or Siam benzoin as an antiseptic agent.
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